Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-02 @ 11:10 PM
Study NCT ID:
NCT06597656
Status:
TERMINATED
Last Update Posted:
2025-09-04
First Post:
2024-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2024-09-12
First Submit QC Date:
None
Study First Post Date:
2024-09-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-09-04
Last Update Post Date Type:
ESTIMATED